USC Legacy Circle members learn more about individualized cancer care

By Ina Fried

A frightened 39-year-old woman with young children was referred by a friend to the USC Norris Comprehensive Cancer Center and Hospital because of recurrent lung cancer. A multidisciplinary team, including a radiologist, pathologist, surgeon and oncologist, evaluated her case.

USC Norris Comprehensive Cancer Center Director Stephen Gruber (left) and Legacy Circle member Jim Bonorris at the Legacy Circle luncheon  Photo/Steve Cohn USC Norris Comprehensive Cancer Center Director Stephen Gruber (left) and Legacy Circle member Jim Bonorris at the Legacy Circle luncheon
Photo/Steve Cohn

Within a week, the woman came to USC Norris, where a lung cancer expert performed minimally invasive robotic surgery. The pathologist performed molecular profiling of her tumor to determine which targeted drugs would be helpful to her.

When USC Norris Director Stephen B. Gruber, MD, MPH, visited the woman the day after surgery, “she was sitting up in bed laughing with her husband and eating ice cream,” he said. Read More »

July 26th, 2013|Announcements|

USC NORRIS HOSTS STOP CANCER

Ram Subramanyan, assistant professor of surgery, speaks at a June 13 STOP CANCER event at the Health Sciences Campus. The event, hosted by USC Norris Comprehensive Cancer Center Director Stephen B. Gruber, recognized STOP CANCER members for their many years of support, and provided an update on the progress of the USC Norris STOP CANCER awardees. Read More »

July 26th, 2013|Announcements|

USC research IDs potential treatment for deadly, HIV-related blood cancer

By Alison Trinidad

Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.

The USC team shows that a class of drugs called BET bromodomain inhibitors effectively targets primary effusion lymphoma (PEL), a type of cancer for which those drugs were not expected to be effective. Read More »

July 12th, 2013|Announcements|

Pfizer and USC team up to create a new R&D partnership

By Amy E. Hamaker

A significant number of drugs originate in the academic medical community, but progress toward translating new pharmaceutical breakthroughs to the clinic is often slow and prohibitively expensive.

Research suggests that since the early 1980s, the number of Food and Drug Administration-approved drugs has stayed the same, while investments in research have increased from $5 billion to $35 billion. Read More »

June 24th, 2013|Announcements|

USC Norris Comprehensive Cancer Center 40th anniversary

As USC celebrates the 40th anniversary of the USC Norris Comprehensive Cancer Center, The Weekly will run in each issue through the end of the year items highlighting key moments in the history of the institution.

On May 10, 1979, ground is broken for the new site of the Kenneth Norris Jr. Cancer Research Institute. At the time, the effort was described as the “largest building project in the 99-year history of the University.” Read More »

June 21st, 2013|Announcements|